Compare Tenet Healthcare Corporation (THC) vs Under Armour Inc Class A (UAA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Under Armour Inc Class A — how do they compare? Tenet Healthcare Corporation trades at $260 (market cap $20.92B), while Under Armour Inc Class A trades at $4.89 (market cap $2.05B). The key difference: Tenet Healthcare Corporation is far larger — about 10.2× Under Armour Inc Class A's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and Under Armour Inc Class A for 99 Days on average.
| THC | UAA | |
|---|---|---|
Market Cap | $20.92B | $2.05B |
Volume | 455,764 | 13,461,776 |
Sector | Health | Consumer Cyclical |
52-Week High | $280.77 | $8.14 |
52-Week Low | $161.37 | $4.17 |
Typical Hold Time | 15 Days | 99 Days |
Enterprise Value | $32.00B | $3.03B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Under Armour (UAA) trades at $4.88 with no change in the latest session. The stock shows mixed signals with a bullish technical outlook but faces fundamental challenges including negative net income margin of -9.99% and declining revenue trends from $5.7B in 2024 to $5.2B in 2025. Recent earnings showed beats in Q4 2025 and Q2 2026 but a miss in Q1 2026. The company is undergoing brand transformation with product focus shifts amid softer demand.
Investment outlook remains cautious with analyst consensus at Buy (27%) but significant Hold ratings (57%). The $5.79 price target suggests 19% upside potential. Key risks include persistent revenue weakness, negative cash flow trends, and competitive pressures in the athletic apparel sector. Margin improvements offer potential upside if demand recovers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Under Armour Inc Class A
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →
